Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease

Area of Science:

• Immunology
• Pulmonary Medicine
• Cell Biology

Background:

• Chronic obstructive pulmonary disease (COPD) involves persistent epithelial and immune cell dysfunction, often exacerbated by infection.
• Previous studies identified innate immune cell involvement in IL-13-dependent chronic lung disease post-infection, but the upstream trigger remained unknown.

Purpose of the Study:

• To investigate the upstream driver of the immune axis in viral-induced chronic lung disease.
• To determine the role of IL-33 in the pathogenesis of chronic obstructive pulmonary disease (COPD).

Main Methods:

• Analysis of parainfluenza virus infection in mouse models.
• Quantification of IL-33 levels in lung tissue from mice and human COPD patients.
• Gene expression analysis of IL-33, IL-13, and mucin.
• Localization of IL-33 gene expression in specific lung cell populations.

Main Results:

• Lung IL-33 levels were significantly elevated in post-viral mice with chronic lung disease and in humans with severe COPD.
• IL-33/IL-33 receptor signaling was essential for IL-13 and mucin gene expression in the mouse model.
• IL-33 expression originated from virus-induced airway serous cells and constitutive alveolar type 2 cells in mice.
• In humans with COPD, IL-33 expression was linked to IL-13 and mucin, originating from airway basal cells with enhanced pluripotency and ATP-regulated IL-33 release.

Conclusions:

• Increased IL-33 is a key mediator in viral-induced chronic lung disease and severe COPD.
• Epithelial progenitor cells programmed for excess IL-33 production represent a paradigm for innate immune system involvement in chronic lung diseases.
• Findings highlight a novel mechanism linking epithelial cell function and innate immunity in COPD pathogenesis.